路透7月10日 - 美国特拉华州最高法院周四裁定，起诉制药商葛兰素史克GSK.L、辉瑞PFE.N、赛诺菲SASY.PA和勃林格殷格翰的患者不能援引几位专家的报告来支持他们关于胃灼热药物Zantac会致癌的说法。
特拉华州最高法院的这一判决是制药商的胜利，商业团体密切关注著这一案件，他们担心不利的判决结果可能会鼓励大规模侵权诉讼，从而损害特拉华州作为商业安全港的声誉。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.